Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Monday, November 8, 2021 at 04:10 PM.
Here’s what investors need to know about the announcement.
Earnings
Arcus Biosciences their estimated earnings by 2.78%, reporting an EPS of $-1.11 versus an estimate of $-1.08, which did not surprise analysts.
Revenue was up $55,069,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.21, which was followed by a 10.56% drop in the share price the next day.
Here’s a look at Arcus Biosciences’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.88 | -0.84 | -0.75 | 0.05 |
| EPS Actual | -1.09 | -1.08 | -0.82 | 0.03 |
| Revenue Estimate | 13.05M | 13.34M | 7.93M | 48.15M |
| Revenue Actual | 9.46M | 9.46M | 9.49M | 64.53M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
